IDEX (IEX) Aperçu de l'action
IDEX Corporation, avec ses filiales, fournit des solutions appliquées aux États-Unis, en Amérique du Nord, en Europe, en Asie et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 1/6 |
| Performances passées | 4/6 |
| Santé financière | 4/6 |
| Dividendes | 4/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour IEX à partir de nos contrôles de risques.
IEX Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
IDEX Corporation Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$221.48 |
| Plus haut sur 52 semaines | US$230.18 |
| Plus bas sur 52 semaines | US$157.25 |
| Bêta | 0.97 |
| Variation sur 1 mois | 1.37% |
| Variation sur 3 mois | 8.09% |
| Variation sur 1 an | 22.45% |
| Variation sur 3 ans | 5.17% |
| Variation sur 5 ans | -0.39% |
| Évolution depuis l'introduction en bourse | 7,566.62% |
Nouvelles et mises à jour récentes
Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaArticle d’analyse • Jun 16
Idex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...
Mise à jour du récit • Jun 16
IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).Recent updates
Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaArticle d’analyse • Jun 16
Idex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...Mise à jour du récit • Jun 16
IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).Mise à jour du récit • Jun 01
IEX: Dividend Strength And AI-Driven Demand Should Support Future Returns
Analysts have maintained their $237.71 price target for IDEX, citing only very small adjustments in the discount rate, revenue growth, profit margin, and future P/E assumptions as the reasons for leaving their valuation unchanged. What's in the News IDEX reported first quarter fiscal 2026 results that came in stronger than expected, according to recent Wall Street coverage.Mise à jour du récit • May 14
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.Mise à jour du récit • Apr 26
IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.Mise à jour du récit • Apr 12
IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).Mise à jour du récit • Mar 28
IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).Mise à jour du récit • Mar 14
IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).Mise à jour du récit • Feb 27
IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).Mise à jour du récit • Feb 13
IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).Mise à jour du récit • Jan 30
IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.Mise à jour du récit • Jan 15
IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.Article d’analyse • Jan 07
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Jul 23
Why IDEX Corporation (NYSE:IEX) Could Be Worth Watching
IDEX Corporation ( NYSE:IEX ) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE...Seeking Alpha • Apr 27
IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaSeeking Alpha • Nov 06
IDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
IDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaSeeking Alpha • Jul 11
IDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking AlphaSeeking Alpha • Jun 30
IDEX: Order Moderation Illuminating A Path Forward
Summary Order moderation in Q1 FY24 indicates initial recovery in end-markets and completion of inventory destocking. IDEX reaffirmed full-year guidance of 0%-2% organic revenue growth, anticipating end-market recovery in the second half of FY24. I predict 7% organic revenue growth from FY25 onwards, with fair value estimated at $220 per share. Read the full article on Seeking AlphaRendement pour les actionnaires
| IEX | US Machinery | US Marché | |
|---|---|---|---|
| 7D | -1.3% | -2.1% | 0.1% |
| 1Y | 22.5% | 38.8% | 20.3% |
Rendement vs Industrie: IEX a sous-performé le secteur US Machinery qui a rapporté 38.8 % au cours de l'année écoulée.
Rendement vs marché: IEX a dépassé le marché US qui a rapporté 20.3 % au cours de l'année écoulée.
Volatilité des prix
| IEX volatility | |
|---|---|
| IEX Average Weekly Movement | 3.2% |
| Machinery Industry Average Movement | 6.6% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: IEX n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de IEX ( 3% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1987 | 8,700 | Eric Ashleman | www.idexcorp.com |
IDEX Corporation, avec ses filiales, fournit des solutions appliquées aux États-Unis, en Amérique du Nord, en Europe, en Asie et dans le monde entier. Elle exerce ses activités par l'intermédiaire de trois segments : Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) et Fire & Safety/Diversified Products (FSDP). Le segment HST conçoit, produit et distribue une gamme de produits fluidiques de précision, de pompes volumétriques, de technologies de traitement des poudres et des liquides, de systèmes de séchage, de composants de microprécision, de composants pneumatiques et de solutions d'étanchéité, de composants d'étanchéité moulés et extrudés à haute performance et de garnitures mécaniques et d'étanchéité d'arbre sur mesure.
IDEX Corporation Résumé des fondamentaux
| IEX statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$16.44b |
| Bénéfices(TTM) | US$507.70m |
| Recettes(TTM) | US$3.53b |
32.3x
Ratio P/E4.6x
Ratio P/SLe site IEX est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| IEX compte de résultat (TTM) | |
|---|---|
| Recettes | US$3.53b |
| Coût des recettes | US$1.96b |
| Marge brute | US$1.57b |
| Autres dépenses | US$1.06b |
| Les revenus | US$507.70m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
Jul 29, 2026
| Résultat par action (EPS) | 6.86 |
| Marge brute | 44.44% |
| Marge bénéficiaire nette | 14.38% |
| Ratio dettes/capitaux propres | 46.2% |
Quelles ont été les performances à long terme de IEX?
Voir les performances historiques et les comparaisonsDividendes
1.3%
Rendement actuel des dividendes31%
Ratio de distributionLe site IEX verse-t-il des dividendes fiables ?
Voir IEX l'historique des dividendes et les indices de référence| IDEX dates des dividendes | |
|---|---|
| Date ex-dividende | Jul 06 2026 |
| Date de paiement du dividende | Jul 24 2026 |
| Jours jusqu'au dividende Ex | 8 days |
| Jours jusqu'à la date de paiement du dividende | 10 days |
Le site IEX verse-t-il des dividendes fiables ?
Voir IEX l'historique des dividendes et les indices de référenceAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/07/13 01:10 |
| Cours de l'action en fin de journée | 2026/07/13 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
IDEX Corporation est couverte par 28 analystes. 14 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |